Exercise Interventions for Overweight Men With Chronic Low Back Pain
NCT07688564, Not applicable, Not yet recruiting, Universiti Sains Malaysia
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Exercise Interventions for Overweight Men With Chronic Low Back Pain | ClinicalTrials.gov |
| NCT number | NCT07688564 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 156 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Universiti Sains Malaysia | ClinicalTrials.gov |
| Conditions | Non-specific Chronic Low Back Pain, Central Sensitization | ClinicalTrials.gov |
| Interventions | Motor Control Exercise, Aerobic Walking Exercise, Muscle Strengthening Exercise, Patient Education | ClinicalTrials.gov |
| First posted | 2026-07-07 | ClinicalTrials.gov |
| Last updated | 2026-07-07 | ClinicalTrials.gov |
Registered outcomes 16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Conditioned Pain Modulation (CPM) | Baseline, 12 weeks, and 6 months after intervention | Conditioned pain modulation (CPM), assessed using the Cold Pressor Test. CPM will be quantified using pressure pain threshold (PPT) measurements obtained before and after the conditioning stimulus. Higher CPM values indicate more effective endogenous pain inhibitory function. | ClinicalTrials.gov |
| Secondary | Pain Intensity | Baseline, 12 weeks, and 6 months after intervention | Change in pain intensity measured using the Numeric Pain Rating Scale (NPRS). Scores range from 0 to 10 points, with higher scores indicating greater pain intensity. | ClinicalTrials.gov |
| Secondary | Disability | Baseline, 12 weeks, and 6 months after intervention | Change in disability measured using the Oswestry Disability Index (ODI). Scores range from 0 to 100 points, with higher scores indicating greater disability related to low back pain. | ClinicalTrials.gov |
| Secondary | Health-Related Quality of Life - Physical Domain | Baseline, 12 weeks, and 6 months after intervention | Change in physical health-related quality of life measured using the WHOQOL-BREF Physical domain. Scores range from 0 to 100, with higher scores indicating better physical quality of life. | ClinicalTrials.gov |
| Secondary | Health-Related Quality of Life - Psychological Domain | Baseline, 12 weeks, and 6 months after intervention | Change in psychological health-related quality of life measured using the WHOQOL-BREF Psychological domain. Scores range from 0 to 100, with higher scores indicating better psychological quality of life. | ClinicalTrials.gov |
| Secondary | Health-Related Quality of Life - Social Relationships Domain | Baseline, 12 weeks, and 6 months after intervention | Change in social relationships measured using the WHOQOL-BREF Social Relationships domain. Scores range from 0 to 100, with higher scores indicating better social quality of life. | ClinicalTrials.gov |
| Secondary | Health-Related Quality of Life - Environment Domain | Baseline, 12 weeks, and 6 months after intervention | Change in environmental quality of life measured using the WHOQOL-BREF Environment domain. Scores range from 0 to 100, with higher scores indicating better environmental quality of life. | ClinicalTrials.gov |
| Secondary | Working Memory | Baseline, 12 weeks, and 6 months after intervention | Change in working memory measured using the Letter-Number Sequencing Test. The outcome will be reported as the total test score, with higher scores indicating better working memory performance. | ClinicalTrials.gov |
| Secondary | Executive Function | Baseline, 12 weeks, and 6 months after intervention | Change in executive function measured using the Stroop Color-Word Test. The outcome will be reported as the Stroop interference score, with higher scores indicating poorer inhibitory control and cognitive flexibility. | ClinicalTrials.gov |
| Secondary | Isometric Trunk Flexion Strength | Baseline, 12 weeks, and 6 months after intervention | Change in peak isometric trunk flexion strength measured using the DIERS myoline system. Higher peak force values indicate greater trunk flexion muscle strength. | ClinicalTrials.gov |
| Secondary | Isometric Trunk Extension Strength | Baseline, 12 weeks, and 6 months after intervention | Change in peak isometric trunk extension strength measured using the DIERS myoline system. Higher peak force values indicate greater trunk extension muscle strength. | ClinicalTrials.gov |
| Secondary | Isometric Trunk Lateral Flexion Strength - Right | Baseline, 12 weeks, and 6 months after intervention | Change in peak isometric right trunk lateral flexion strength measured using the DIERS myoline system. Higher peak force values indicate greater muscle strength. | ClinicalTrials.gov |
| Secondary | Isometric Trunk Lateral Flexion Strength - Left | Baseline, 12 weeks, and 6 months after intervention | Change in peak isometric left trunk lateral flexion strength measured using the DIERS myoline system. Higher peak force values indicate greater muscle strength. | ClinicalTrials.gov |
| Secondary | Isometric Trunk Rotation Strength - Right | Baseline, 12 weeks, and 6 months after intervention | Change in peak isometric right trunk rotation strength measured using the DIERS myoline system. Higher peak force values indicate greater muscle strength. | ClinicalTrials.gov |
| Secondary | Isometric Trunk Rotation Strength - Left | Baseline, 12 weeks, and 6 months after intervention | Change in peak isometric left trunk rotation strength measured using the DIERS myoline system. Higher peak force values indicate greater muscle strength. | ClinicalTrials.gov |
| Secondary | Body Weight | Baseline, 12 weeks, and 6 months after intervention | Change in body weight measured using a calibrated digital scale and reported in kilograms (kg). | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Letter-Number Sequencing Task | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)